Gartner Research

An Assessment of Global Regulations Across the Healthcare Value Chain Requiring Track and Trace With Serialization

Published: 05 February 2020

ID: G00418228

Analyst(s): Andrew Stevens

Summary

Supply chain leaders across the life science industry and healthcare value chain can use this assessment of the current and upcoming global regulatory landscape to fully comprehend the requirements and modes of execution for adopting track and trace with serialization.

Table Of Contents

Analysis

  • Definitions of Counterfeit and Fake Medicines or Products
  • Market Dynamics Behind Counterfeit and/or Fake Pharmaceuticals, and the Business Need for Track and Trace With Serialization
  • Data and Coding Building Blocks That Shape Global Regulations
    • Batch Coding
    • Serialization (and Serial Numbers)
    • Track and Trace
    • Product Authentication and Verification
  • Decision Making and Challenges for Deployments of Track and Trace With Serialization as Part of IT Infrastructure for Aligned Compliance Mandates
  • The Current Global Status of the Regulatory Outlook for Track-and-Trace With Serialization Regulations
  • Prioritize These Seven Countries and/or Regions for Phased Compliance Deadlines Across 2020 and Into 2021 for Batch Coding, and Track-and-Trace With Serialization Compliance Mandates
  • Recommendations

Gartner Recommended Reading

©2021 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. and its affiliates. This publication may not be reproduced or distributed in any form without Gartner’s prior written permission. It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact. While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information. Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such. Your access and use of this publication are governed by Gartner’s Usage Policy. Gartner prides itself on its reputation for independence and objectivity. Its research is produced independently by its research organization without input or influence from any third party. For further information, see Guiding Principles on Independence and Objectivity.

Already have a Gartner Account?

Become a client

Learn how to access this content as a Gartner client.